AstraZeneca
AZN
$70.82
Share price
1.14%
Change (1 day)
-7.63%
Change (1 year)
Categories
EPS for AstraZeneca (AZN)
EPS in 2025 (TTM): $2.50
According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $2.50. In 2024 the company made an earnings per share (EPS) of $2.27 an increase over its 2023 EPS that were of $1.92.
EPS history for AstraZeneca from 2011 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | $2.50 | 10.35% |
| 2024 | $2.27 | 18.23% |
| 2023 | $1.92 | 81.13% |
| 2022 | $1.06 | 631.03% |
| 2021 | $0.14 | -88.11% |
| 2020 | $1.22 | 136.89% |
| 2019 | $0.51 | -39.41% |
| 2018 | $0.85 | -28.27% |
| 2017 | $1.18 | -14.37% |
| 2016 | $1.38 | 24.11% |
| 2015 | $1.12 | 127.55% |
| 2014 | $0.49 | -51.96% |
| 2013 | $1.02 | -58.95% |
| 2012 | $2.48 | -32.2% |
| 2011 | $3.66 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | $2.68 | 6.99% | 🇺🇸 USA |
 Pfizer PFE | $1.39 | -44.51% | 🇺🇸 USA |
 Merck MRK | $6.90 | 175.34% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $1.56 | -37.73% | 🇬🇧 UK |
 Sanofi SNY | $2.85 | 13.66% | 🇫🇷 France |
 Eli Lilly LLY | $12.36 | 393.25% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $9.07 | 261.98% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.79 | 210.85% | 🇺🇸 USA |
 Biogen BIIB | $10.16 | 305.59% | 🇺🇸 USA |
 Novartis NVS | $6.43 | 156.69% | 🇨🇭 Switzerland |